| Over 20% of men and 24% of women living in developed countries
suffer from obesity. The current methods of treating obesity do not take gender
into consideration, and differences in male and female metabolism have not been
discussed for some time. The aim of our research is to find out the effectiveness
of the Medislim program on obese men and women.
Materials and methods
We performed a preliminary statistic analysis of 54 case histories of patients
without somatic pathology who had been undergoing Medislim treatment for 3 months.
Among the patients, 36 were women (66.66%) and 18 were men (33.33%). The Body
Mass Index (BMI) levels of the female group ranged from 33.3 to 46.6. The BMI
levels of the male group ranged from 32.1 to 44.4. The investigated characteristics
included weight, blood sugar, general cholesterol, triglyceride, SGOT and SGPT.
The result of the research
In the female group, most patients (88.88%) had BMI levels of 33.3 - 33.6; 8 patients
(22.2%) had an above-normal blood sugar level of 128.98mg (p<0.001); 8 patients
(22.2%) had an above-normal cholesterol level of 283.23 n (p<0.001); 10 patients
(27.7%) had an above-normal triglyceride level of 274.3 (p<0.001); 6 patients
(16.66%) had an above-normal SGOT of 52 units (p<0.001); and 10 patients (27.7%)
had an above-normal SGPT of 54.36 units (p<0.001).
The observed weight loss in the female group during the 3 months of treatment
averaged at 8.48 kg, or 9.04% of the body weight.
As a result of the treatment, blood sugar and cholesterol levels decreased
to normal for all patients. We also noticed a normalization of triglyceride levels
at 226m, SGOT levels at 42.16 units, and SGPT levels at 43.36 units during treatment.
In the male group, most patients (72.22%) had a BMI level of 32.1. The rest
(27.77%) had a BMI level of 44.4. 7 patients (38.88%) had an above-normal blood
sugar level of 136.2 mg (p<0.001); 8 patients (44.4%) had an above-normal cholesterol
level of 294n (p<0.001); 10 patients (55.55%) had an above-normal triglyceride
level of 318m (p<0,001); 4 patients (22.22%) had an above-normal SGPT level
of 42 units (p<0.001); and 11 patients (61.1%) had an above-normal SGOT level
of 54.72 units (p<0.001).
The observed weight loss in the male group during 3 months of treatment averaged
at 10.17 kg, or 11.6% of the body weight.
As a result of the treatment, blood sugar levels decreased to normal for all
patients having hyperglycemia (38.88%). We also noticed a normalization of cholesterol
levels at 252.18n, triglyceride levels at 247.25m, and SGPT levels at 44.25 units
during treatment.
Table 2: The investigated characteristics of Male and Female groups:
| Groups |
Weight (kg) |
% |
BMI |
FBS(mg%) |
CH(n) |
TR(m) |
SGOT(unit) |
SGPT (unit) |
| 1 |
2 |
1 |
2 |
1 |
2 |
1 |
2 |
1 |
2 |
1 |
2 |
| F |
36 |
97.05 |
88.57 |
9.04 |
37.8 |
128.9 |
97.9 |
283.2 |
236.7 |
274.3 |
226 |
52 |
42 |
54.36 |
43.36 |
| M |
18 |
117.6 |
107.4 |
11.6 |
38.2 |
136.2 |
101.7 |
284.5 |
252.2 |
318 |
247.2 |
42 |
42 |
54.72 |
44.25 |
|
